1. Home
  2. FLNT vs NRXS Comparison

FLNT vs NRXS Comparison

Compare FLNT & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$3.39

Market Cap

90.9M

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$6.83

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNT
NRXS
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
90.9M
78.9M
IPO Year
2009
2023

Fundamental Metrics

Financial Performance
Metric
FLNT
NRXS
Price
$3.39
$6.83
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$3.50
$13.00
AVG Volume (30 Days)
220.9K
114.1K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
41.67
22.13
EPS
N/A
N/A
Revenue
$208,764,000.00
$3,569,282.00
Revenue This Year
$5.89
$172.91
Revenue Next Year
$12.62
$115.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.89
52 Week Low
$1.70
$2.20
52 Week High
$4.15
$9.33

Technical Indicators

Market Signals
Indicator
FLNT
NRXS
Relative Strength Index (RSI) 69.96 43.92
Support Level $2.95 $6.79
Resistance Level $3.57 $7.79
Average True Range (ATR) 0.30 0.37
MACD 0.15 0.03
Stochastic Oscillator 94.57 43.75

Price Performance

Historical Comparison
FLNT
NRXS

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: